Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial May 1, 2021
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice April 27, 2021
Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression March 29, 2021
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes March 23, 2021
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action March 19, 2021
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review March 7, 2021
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property February 26, 2021
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment-resistant depression February 21, 2021
Single, Fixed-Dose Intranasal Ketamine for Alleviation of Acute Suicidal Ideation. An Emergency Department, Trans-Diagnostic Approach: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial February 14, 2021
